Morgan Hanger is the Executive Director of the Clinical Trials Transformation Initiative (CTTI), a public-private partnership between Duke University and the U.S. Food and Drug Administration. She specializes in bringing together diverse stakeholders to translate complex perspectives into practical solutions that improve how clinical trials are designed and conducted.

Morgan has held leadership roles at health technology companies focused on improving patient experiences—streamlining specialty product access, simplifying Medicare plan selection, and advancing learning through data sharing. As Vice President at PatientsLikeMe, she led initiatives to integrate patient-generated health data into life sciences and regulatory settings, developing tools to enhance clinical trial design and support decentralized trials. At Avalere Health, she advised pharmaceutical and biotech companies on health economics and outcomes research strategy.

Morgan also conducted health outcomes research at Memorial Sloan Kettering Cancer Center, with a focus on equity and cost in oncology, and policy analysis at the Congressional Budget Office on federally supported comparative effectiveness research.

She holds a Bachelor of Arts in Politics, summa cum laude, from New York University and a Master of Public Policy from the University of California, Berkeley..